Aquatic Capital Management LLC Vericel Corp Transaction History

Aquatic Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$32.52 - $52.33 $162,600 - $261,650	5,000 Added 200.0%	7,500 $390,000
Q4 2023 Feb 14, 2024	BUY	$30.85 - $37.09 $77,125 - $92,725	2,500 New	2,500 $89,000
Q2 2023 Aug 14, 2023	BUY	$29.0 - $38.37 $2,900 - $3,836	100 Added 1.49%	6,800 $255,000
Q1 2023 May 15, 2023	BUY	$23.85 - $31.34 $159,795 - $209,978	6,700 New	6,700 $196,000
Q2 2022 Aug 15, 2022	BUY	$22.88 - $39.45 $32,032 - $55,230	1,400 New	1,400 $35,000
Q1 2022 May 16, 2022	SELL	$31.69 - $43.29 $15,845 - $21,645	-500 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$35.2 - $52.6 $17,600 - $26,300	500 New	500 $20,000

279

48.7M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.76B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.